The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $127.21

Today's change+0.20 +0.16%
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $127.21

Today's change+0.20 +0.16%
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.

United Therapeutics Corp Hits New 20-day High

United Therapeutics Corp closed up Friday by (U.S.)$0.20 or 0.16% to (U.S.)$127.21 and setting a new 20-day high. Over the last five days, shares have gained 3.16%, but are down 18.77% for the last year to date. Shares have underperformed the S&P 500 by 22.06% during the last year.

Key company metrics

  • Open(U.S.) $126.54
  • Previous close(U.S.) $127.01
  • High(U.S.) $127.79
  • Low(U.S.) $125.73
  • Bid / Ask-- / --
  • YTD % change-18.77%
  • Volume489,809
  • Average volume (10-day)624,280
  • Average volume (1-month)507,242
  • Average volume (3-month)560,330
  • 52-week range(U.S.) $97.52 to (U.S.) $164.04
  • Beta1.40
  • Trailing P/E6.18×
  • P/E 1 year forward8.08×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $20.58
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.67%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue413369405386
Total other revenue--------
Total revenue413369405386
Gross profit393368380379
Total cost of revenue201257
Total operating expense1275250-1
Selling / general / administrative725149-17
Research & development3507610
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income285364155387
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets----0350
Other--------
Income before tax286364156737
Income after tax206236105464
Income tax, total8012851272
Net income206236105464
Total adjustments to net income--------
Net income before extra. items206236105464
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items206236105464
Inc. avail. to common incl. extra. items206236105464
Diluted net income206236105464
Dilution adjustment--------
Diluted weighted average shares47495050
Diluted EPS excluding extraordinary itemsvalue per share4.394.842.109.24
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share4.394.842.104.85